Dr. Ferric Fang and his colleagues at the UW have uncovered the mechanisms through which the bacteria Staph aureus, seen here in clusters under an electron microscope, can protect itself against our body's natural defenses. Fang's research was featured on the cover of Science magazine on March 21. Image courtesy of Science magazine.Â
Researchers at the University of Washington have uncovered how the bacterium Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA) "superbug" strains, resists the body's natural defenses against infection. The work, which was featured on the cover of the March 21 issue of Science, could lead to new ways to fight the bacteria.
Dr. Ferric Fang, UW professor of laboratory medicine and microbiology, and his UW colleagues Dr. Anthony Richardson and Dr. Stephen Libby, set out to determine what makes Staphylococcus aureus a better pathogen than other bacteria. They focused on a chemical compound called nitric oxide (NO), a natural antibiotic that our cells excrete to protect us from pathogens. For most bacteria, NO creates an environment that keeps invading microbes from undergoing respiration or fermentation, vital chemical processes that allow bacteria to grow.
The researchers found that S. aureus has a mechanism that allows it to produce lactic acid in the presence of NO, which allows it to maintain its chemical balance and keep growing and thriving in the harsh host environment. When S. aureus is exposed to NO, it produces the novel enzyme responsible for lactic acid production, along with another enzyme that converts NO to non-toxic products. NO is commonly found in the nose and nasal passages, and is meant to protect people against disease-causing microbes. But S. aureus is commonly found in the nose despite the presence of NO, the researchers explained.
When the researchers modified S. aureus to take away its ability to make lactic acid, the bacteria could no longer tolerate NO. The modified bacteria also lost their ability to survive in host immune cells and cause lethal disease in mice.
"MRSA has become an enormous public health problem, by causing both hospital- and community-acquired infections," explained Fang. "S. aureus has already colonized about one-third of the world's population, so traditional antibiotics will probably not be the complete answer to the MRSA problem."
However, the researchers added, trying to make S. aureus more susceptible to the bodys natural defenses might lead to new strategies to de-colonize the population and prevent staphylococcal infections.
Source: University of Washington
Â
Â
Â
The Sterile Processing Conference Survival Guide: How to Make the Most of Your Next Event
March 25th 2025From expert speakers to cutting-edge tools, sterile processing conferences, like the 2025 HSPA Annual Conference and the SoCal SPA's Spring Conference, offer unmatched opportunities to grow your skills, expand your network, and strengthen your department's infection prevention game.
Redefining Material Compatibility in Sterilization: Insights From AAMI TIR17:2024
March 24th 2025AAMI TIR17:2024 provides updated, evidence-based guidance on material compatibility with sterilization modalities. It offers essential insights for medical device design and ensures safety without compromising functionality.